Production of metal-organic frameworks
US-2016346757-A1 · Dec 1, 2016 · US
US2017182486A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017182486-A1 |
| Application number | US-201515129853-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 30, 2015 |
| Priority date | Mar 28, 2014 |
| Publication date | Jun 29, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Metal-organic framework (MOFs) compositions based on nitrogen donor-based organic bridging ligands, including ligands based on 1,3-diketimine (NacNac), bipyridines and salicylaldimine, were synthesized and then post-synthetically metalated with metal precursors, such as complexes of first row transition metals. Metal complexes of the organic bridging ligands could also be directly incorporated into the MOFs. The MOFs provide a versatile family of recyclable and reusable single-site solid catalysts for catalyzing a variety of asymmetric organic transformations. The solid catalysts can also be integrated into a flow reactor or a supercritical fluid reactor.
Opening claim text (preview).
1 . A method for preparing a crystalline and porous metal-organic framework (MOF), wherein said crystalline and porous MOF comprises periodic repeats of a metal-based secondary building unit (SBU) and a nitrogen donor-based bridging ligand, said method comprising: providing a nitrogen donor-based bridging ligand; and contacting the nitrogen donor-based bridging ligand with a first metal source to obtain the crystalline and porous MOF. 2 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand is a derivative of one of the nitrogen donor moieties selected from the group comprising bipyridines, phenanthrolines, terpyridines, salicylaldimines, pyridylphenols, 1,3-diketimine (NacNac), and bis(oxazolines). 3 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand is a derivative of a nitrogen donor moiety, wherein the nitrogen donor moiety is substituted by one or more substituents selected from a carboxylate, pyridine, and/or phosphonate moiety. 4 . The method of claim 3 , wherein the nitrogen donor-based bridging ligand is a dicarboxylate, a tricarboxylate, a tetracarboxylate, a bipyridine, a tripyridine, a tetrapyridine, a diphosphonate, a triphosphonate, or a tetraphosphonate derivative of a nitrogen donor moiety. 5 . The method of claim 3 , wherein the nitrogen donor-based bridging ligand is a nitrogen donor moiety substituted with at least two substituents selected from the group comprising carboxylate, pyridine, and phosphonate. 6 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand is a carboxylate, pyridine, or phosphonate derivative of a nitrogen donor moiety selected from the group comprising bipyridines, phenanthrolines, terpyridines, salicylaldimines, pyridylphenols, and bis(oxazolines). 7 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand is a dicarboxylate-substituted bipyridine, phenanthroline, terpyridine, salicylaldimine, pyridylphenol, 1,3-diketimine (NacNac), or bis(oxazoline). 8 . The method of claim 1 , wherein said nitrogen-donor based bridging ligand is not a derivative of an N,N′-alkylenebis(salicylimine) or a derivative of an N,N′-arylenebis(salicylimine). 9 . The method of claim 1 , wherein the SBU is selected from the group comprising Hf-oxo clusters, Zr-oxo clusters, Zn-oxo clusters, Ti-oxo clusters, Cu-carboxylate paddlewheels, and other SBUs used to construct MOFs. 10 . The method of claim 1 , wherein the first metal source is a metal alkoxide or a metal halide. 11 . The method of claim 1 , wherein the first metal source is ZrCl 4 . 12 . The method of claim 1 , further comprising contacting the crystalline and porous MOF with a second metal source to metalate the bridging ligand. 13 . The method of claim 12 , wherein the second metal source comprises Fe, Co, Ni, Rh, Ru, Ir, Os, Pt, Pd, V, Cr, Mn or Cu. 14 . The method of claim 12 , wherein the second metal source is FeCl 3 , CoCl 2 , NiCl 2 . 15 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand is a chiral bridging ligand. 16 . The method of claim 1 , wherein the MOF further comprises a bridging ligand that is not a nitrogen donor-based bridging ligand. 17 . The method of claim 1 , wherein the nitrogen donor-based bridging ligand and the first metal source are contacted in a solvent or mixture of solvents selected based on solvent molecule size, such that the sizes and/or shapes of internal pores, cavities, and/or open channels in the crystalline and porous MOF can be tailored to enhance catalytic activity and selectivity. 18 . A heterogeneous catalyst comprising a crystalline and porous MOF, wherein said crystalline and porous MOF comprises periodic repeats of a metal-based secondary building unit (SBU), wherein said metal-based SBU comprises a first metal, and a nitrogen donor-based bridging ligand, wherein said nitrogen donor-based bridging ligand is further complexed to a second metal. 19 . A heterogeneous catalyst prepared according to the method of claim 1 . 20 . A method for preparing a compound comprising contacting a substrate capable of forming a product by catalytic transformation with a heterogeneous catalyst of claim 18 . 21 . The method of claim 20 , wherein the catalytic transformation is selected from the group comprising hydrogenation; dehydrogenation; isomerization, optionally the isomerization of an allylamine, an allyl alcohol, or an α,β-unsaturated ketone; allylic substitution; a coupling reaction, optionally wherein the coupling reaction is a Buchwald-Hartwig amination, an intramolecular Heck reaction, or an intermolecular Heck reaction; conjugate addition, optionally wherein the conjugate addition is a Michael addition or an azo-Michael addition; an aldol reaction; a Mannich-type reaction; nucleophilic addition, optionally wherein the nucleophilic addition is to a carbonyl or imine group and/or wherein the nucleophilic addition is a cyanation, a propargylation, an allylation, a dienylation, an arylation, an alkenylation, or an alkylation; hydroformylation; hydroacylation; hydroboration; hydroamination; intra- or intermolecular hydrosilylation; an α-substitution reaction, optionally wherein the α-substitution reaction is a protonation, a fluorination, an amination, an arylation, or an orthoester alkylation; an ene reaction; a Diels-Alder reaction; a Pauson-Khand reaction; an enyne intramolecular cyclization; a [2+2+2] cycloaddition; a [3+2] cycloaddition; and a ring-opening reaction.
by hydrogenation of carbon-to-carbon double or triple bonds · CPC title
Iridium · CPC title
having no double bonds between ring members or between ring members and non-ring members · CPC title
Zirconium · CPC title
Palladium · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.